Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on brain & cognitive health. Browse all Brain & Cognitive Health education

Aggression is not a single trait with a single cause. It emerges from an interplay of brain chemistry, stress, upbringing, and — as decades of research now show — inherited differences in how the brain produces and clears its signaling molecules. Twin studies estimate that roughly 40–60% of the variation in aggressive tendencies is heritable, though no single "aggression gene" acts alone.

What researchers mean by aggression

Behavioral scientists separate reactive aggression (impulsive responses to perceived threat) from proactive aggression (planned, goal-directed behavior). The two engage different circuits. Reactive aggression leans heavily on the amygdala and its regulation by the prefrontal cortex, while proactive aggression involves reward pathways. Genetics influence both by shaping the availability of neurotransmitters such as dopamine and serotonin.

MAOA: the most-studied gene in aggression research

The MAOA gene encodes monoamine oxidase A, an enzyme that breaks down dopamine, serotonin, and norepinephrine. A well-characterized variable-number tandem repeat in the gene promoter (MAOA-uVNTR) produces higher- or lower-activity versions of the enzyme. The low-activity form, sometimes labeled in the press as the "warrior gene," has been associated with greater impulsive aggression in some studies. A landmark 2002 analysis by Caspi and colleagues found the effect largely depended on childhood maltreatment — genotype alone did not predict behavior. A rare loss-of-function MAOA mutation was also identified in Brunner syndrome, an unusual familial condition marked by impulsive aggression.

COMT Val158Met and dopamine clearance

The COMT gene (variant rs4680, known as Val158Met) sets how quickly the enzyme catechol-O-methyltransferase clears dopamine from the prefrontal cortex. The Val version clears dopamine faster; the Met version leaves more dopamine available. Research has linked COMT genotype to differences in emotional regulation, stress reactivity, and, in some cohorts, hostility — but effects are modest and context-dependent. COMT rarely acts in isolation; it interacts with stress hormones and other pathway genes.

Serotonin signaling and the amygdala

Serotonin helps put the brakes on impulsive behavior. Variation in the serotonin transporter gene SLC6A4 (the 5-HTTLPR region) has been studied for its role in stress sensitivity and emotional reactivity. Because serotonin tone shapes how strongly the amygdala fires and how well the prefrontal cortex restrains it, these genes sit upstream of the circuitry that governs anger responses. The picture is genuinely polygenic: many small-effect variants combine with environment.

Genes set tendencies, not verdicts

The consistent message across this literature is gene–environment interaction. A given genotype may raise or lower sensitivity to stress, sleep loss, or early-life adversity, but behavior is shaped by all of it together. Epigenetic changes — how genes are switched on and off — add another layer that responds to experience over a lifetime. Evidence-based approaches to managing anger, including cognitive behavioral strategies, sleep, and professional support, work regardless of genotype.

What genetic pathway context can add

Understanding your inherited tendencies is one input among many. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including neurotransmitter-related pathways connected to genes such as COMT and MAOA. It reports pathway-level context — not a diagnosis and not a behavioral prediction. Genetics is a guide, not a guarantee, and results are most useful when discussed with a qualified provider who knows your full history.

Frequently Asked Questions

Is there really a "warrior gene" for aggression?

The low-activity MAOA variant has been nicknamed the "warrior gene," but that label oversimplifies the science. Studies show its association with aggression depends heavily on childhood environment and other factors. No single gene determines aggressive behavior, and genotype alone cannot predict how any individual will act.

Does the COMT Val158Met variant make someone more aggressive?

COMT rs4680 influences how quickly dopamine is cleared from the prefrontal cortex, which affects stress reactivity and emotional regulation. Some studies link certain genotypes to hostility, but effects are small and context-dependent. It is one contributing pathway among many, not a cause of aggression on its own.

Can I change genetically influenced aggression?

You cannot change your genotype, but behavior is highly modifiable. Evidence-based tools — cognitive behavioral therapy, stress and sleep management, and professional support — help regardless of genetics. Gene expression also responds to environment over time, which is why lifestyle and therapy remain central.

Curious how your own biology maps to these pathways? The Precision Peptide Genetic Test gives you pathway-level genetic context to bring into an informed conversation with your healthcare provider — test before you invest.

Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not diagnose, treat, cure, or prevent any condition, and it does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.

This article is part of the PlexusDx Education Hub. Browse all Brain & Cognitive Health education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.